From: Palliative treatment of pelvic bone tumors using radioiodine (125I) brachytherapy
 |  |  |  | Pre-implantation tumor characteristics | Post-implantation (1 month) tumor characteristics | ||||
---|---|---|---|---|---|---|---|---|---|
Gender | Age | Pathological type | Dose (cGy) | Major axis (cm) | Minor axis (cm) | Volume (cm3) | Major axis (cm) | Minor axis (cm) | Volume (cm3) |
M | 34 | Chordoma | 80 | 16.7 | 10.2 | 839.2 | 14.5 | 9.1 | 604.65 |
M | 58 | Chordoma | 30 | 10.1 | 7.9 | 314.7 | 6.6 | 5.2 | 88 |
M | 58 | Chordoma | 100 | 22 | 14.4 | 2288 | 22 | 14.6 | 2346.3* |
M | 84 | Chordoma | 100 | 19.1 | 12.3 | 1441.7 | 14.8 | 11.8 | 1025.64 |
F | 43 | Chordoma | 50 | 8 | 3.7 | 54.4 | 7 | 3.3 | 39.2 |
F | 47 | Chordoma | 30 | 13.3 | 6.3 | 267.9 | 12.1 | 4.9 | 148.1 |
M | 20 | GCT | 20 | 8.9 | 5.6 | 142 | 8 | 5.1 | 111 |
M | 30 | GCT | 100 | 20 | 11.6 | 1350 | 18 | 9.2 | 768.6 |
F | 64 | GCT | 60 | 6 | 4.7 | 67.5 | 5.8 | 4 | 46.4 |
M | 75 | Osteosarcoma | 70 | 9.8 | 3.9 | 76.3 | 9.7 | 3.5 | 60.5 |
F | 15 | Osteosarcoma | 80 | 18 | 9.6 | 828 | 14.7 | 8.9 | 582.12 |
F | 20 | Osteosarcoma | 60 | 15.6 | 9.4 | 683.3 | 9.7 | 8.1 | 494.7 |
M | 39 | Chondrosarcoma | 30 | 10.3 | 6.9 | 248 | 9.1 | 6.1 | 168 |
M | 46 | Chondrosarcoma | 20 | 9.3 | 6.5 | 195.3 | 6.6 | 5.7 | 107.1 |
M | 54 | Fibrosarcoma | 100 | 20.9 | 12.7 | 1681.6 | 19.7 | 12 | 1427.3 |
F | 60 | Fibrosarcoma | 40 | 14.4 | 8.1 | 474.2 | 15.3 | 8.3 | 523.3* |
F | 24 | Malignant melanoma | 30 | 10.7 | 7.4 | 293.9 | 10 | 6.5 | 209 |
F | 50 | Malignant melanoma | 30 | 10 | 7.7 | 368 | 9.5 | 7.5 | 267 |
M | 39 | B-DLCL | 20 | 8.5 | 5.8 | 142.8 | 3.8 | 2.7 | 13.4 |
F | 44 | Hemangioma | 10 | 7.4 | 4.6 | 79.5 | 6.5 | 3.9 | 50.7 |
M | 61 | Leiomyosarcoma | 100 | 14.7 | 12.1 | 1070 | 15 | 13.1 | 1300.7* |
F | 16 | Mesenchymal neoplasm | 10 | 7.8 | 3.6 | 49.2 | 7.2 | 3.1 | 34 |
n = 22 Median (IQR) | 45 (27.5–85.0) | 10.5 (8.8–17.0) | 7.55 (5.4–10.6) | 304.3 (126.4–896.9) | 9.7 (6.9–14.9) | 6.3 (4.0–9.1) | 188.5 (58.05–645.6) |